SCHEMBL26415503

SCHEMBL26415503

c1ccc(-c2nc3ccccc3nc2-c2cc(-c3ccc4cc(N(c5ccccc5)c5ccccc5)ccc4c3)cc3oc4ccccc4c23)cc1

nearest known ligand 0.33

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 5/20 0.33
KDM4E B2RXH2 5/20 0.33
ALDH1A1 P00352 5/20 0.33
LMNA P02545 4/20 0.33
TDP1 Q9NUW8 2/20 0.33
NPSR1 Q6W5P4 2/20 0.33
GAA P10253 2/20 0.33
MEN1 O00255 1/20 0.33
KMT2A Q03164 1/20 0.33
PIK3CD O00329 1/20 0.32
PIK3CA P42336 1/20 0.32
PIK3CB P42338 1/20 0.32
MTOR P42345 1/20 0.32
PIK3CG P48736 1/20 0.32
PSMB5 P28074 1/20 0.32
THRB P10828 1/20 0.31
CYP3A4 P08684 1/20 0.31
CYP2C9 P11712 1/20 0.31
ALOX12 P18054 1/20 0.31
CYP2C19 P33261 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26415506 0.95 L3MBTL1 (0.32) L3MBTL1
SCHEMBL26416601 0.93 L3MBTL1 (0.34) L3MBTL1KDM4EALDH1A1LMNATDP1
SCHEMBL26415510 0.91 L3MBTL1 (0.33) L3MBTL1KDM4EALDH1A1LMNATDP1
SCHEMBL25057649 0.90 L3MBTL1 (0.34) L3MBTL1KDM4EALDH1A1LMNATDP1
SCHEMBL26415659 0.89 L3MBTL1 (0.36) L3MBTL1KDM4EALDH1A1LMNATDP1
SCHEMBL26415666 0.85 L3MBTL1 (0.33) L3MBTL1KDM4EALDH1A1LMNATDP1
SCHEMBL26415472 0.85 MAPT (0.32) KDM4EALDH1A1LMNAMEN1KMT2A
SCHEMBL26415667 0.84 PSMB5 (0.34) L3MBTL1KDM4EALDH1A1LMNATDP1
SCHEMBL26415498 0.84 L3MBTL1 (0.31) L3MBTL1KDM4EALDH1A1TDP1MEN1
SCHEMBL27391336 0.83 L3MBTL1 (0.36) L3MBTL1KDM4EALDH1A1LMNATDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230128360-A1 HETEROCYCLIC COMPOUND, ORGANIC LIGHT EMITTING DEVICE COMPRISING SAME, COMPOSITION FOR ORGANIC LAYER OF ORGANIC LIGHT EMITTING DEVICE LT MATERIALS CO., LTD. (KR) 2023-04-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230128360-A1 HETEROCYCLIC COMPOUND, ORGANIC LIGHT EMITTING DEVICE COMPRISING SAME, COMPOSITION FOR ORGANIC LAYER OF ORGANIC LIGHT EMITTING DEVICE CRY1, ORC3, ODC1 L3MBTL1 2788/4885KDM4E 3080/4885ALDH1A1 27/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.